Where's it on?
FDA · Drugs ·

Buprenorphine Sublingual Tablets (C-III) recall

American Health Packaging recalled Buprenorphine Sublingual Tablets (C-III) on September 9, 2026 because of labeling: Label Mix-up. It was sold nationwide.

Why it was recalled

Labeling: Label Mix-up

What's recalled

Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11).

Quantity: 10,953 cartons.

What to do

Check whether you have the product (match the lot numbers, dates or codes in the official notice). Stop using it, and return it or throw it away as the notice says.

Read the official FDA notice